AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (June 6, 2006). doi:10.1152/ajpendo.00024.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/E899    most recent
00024.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jorgensen, J. O. L.
Right arrow Articles by Billestrup, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jorgensen, J. O. L.
Right arrow Articles by Billestrup, N.
Submitted on January 18, 2006
Accepted on May 30, 2006

Growth Hormone Receptor Signaling in Skeletal Muscle and Adipose Tissue in Human Subjects Following Exposure to an Intravenous GH Bolus

Jens Otto Lunde Jorgensen1*, Niels Jessen1, Steen B Pedersen2, Esben Vestergaard1, Lars Gormsen1, Sten A Lund1, and Nils Billestrup3

1 Medical Department M, Aarhus University Hospital, Aarhus, Denmark; Institute of Clinical Research, Aarhus University, Aarhus, Denmark
2 Institute of Clinical Research, Aarhus University, Aarhus, Denmark
3 Steno Diabetes Center, Copenhagen, Denmark

* To whom correspondence should be addressed. E-mail: joj{at}afdm.au.dk.

Context: GH regulates muscle and fat metabolism, which impacts on body composition and insulin sensitivty, but GH signaling pathways have not been studied in vivo in humans. Objective: We investigated GH signaling in muscle and fat biopsies obtained 30 (n=3) or 60 (n=3) min after an intravenous bolus of GH (0.5 mg) versus saline together with serum sampling in six fasting healthy males. Methods: The expression of the following signal proteins were assayed by Western Blotting: STAT5/pSTAT5, MAPK, and Akt/PKB. IRS1-associated PI 3-kinase activity was measured by in vitro phosphorylation of PI. STAT5 DNA binding activity was assessed with EMSA, and the expression of IGF-I and SOCS mRNA was measured by real-time RT-PCR. Results: GH induced a 52 % increase in circulating FFA levels (P=0.03). Tyrosine phosphorylated STAT5 was detected in muscle and fat of all subjects after GH. Activation of MAPK was observed in several lysates but without GH- dependency. Neither PKB/Akt nor PI 3-kinase activity was affected by GH. GH-induced STAT5 DNA binding and expression of IGF-I mRNA were detected in fat, whereas expression of SOCS1 and SOCS3 tended to increase after GH in muscle and fat. Conclusions: 1) STAT5 is acutely activated in human muscle and fat after a GH bolus, and furtherl downstream GH signaling was significant in fat 2) The direct GH effects in muscle need further characterisation 3) This model may be used to study the mechanisms subserving the in vivo actions of GH on substrate metabolism and insulin sensitivity in muscle and fat.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. B. Krag, L. C. Gormsen, Z. Guo, J. S. Christiansen, M. D. Jensen, S. Nielsen, and J. O. L. Jorgensen
Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E920 - E927.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.